Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

164 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Epidural Stimulation Combined with Triple Gene Therapy for Spinal Cord Injury Treatment.
Islamov R, Bashirov F, Fadeev F, Shevchenko R, Izmailov A, Markosyan V, Sokolov M, Kuznetsov M, Davleeva M, Garifulin R, Salafutdinov I, Nurullin L, Chelyshev Y, Lavrov I. Islamov R, et al. Among authors: shevchenko r. Int J Mol Sci. 2020 Nov 24;21(23):8896. doi: 10.3390/ijms21238896. Int J Mol Sci. 2020. PMID: 33255323 Free PMC article.
CYP2C19*17 May Increase the Risk of Death Among Patients with an Acute Coronary Syndrome and Non-Valvular Atrial Fibrillation Who Receive Clopidogrel and Rivaroxaban.
Sychev DA, Baturina OA, Mirzaev KB, Rytkin E, Ivashchenko DV, Andreev DA, Ryzhikova KA, Grishina EA, Bochkov PO, Shevchenko RV. Sychev DA, et al. Among authors: shevchenko rv. Pharmgenomics Pers Med. 2020 Jan 23;13:29-37. doi: 10.2147/PGPM.S234910. eCollection 2020. Pharmgenomics Pers Med. 2020. PMID: 32158254 Free PMC article.
Influence of ABCB1, CYP3A5 and CYP3A4 gene polymorphisms on prothrombin time and the residual equilibrium concentration of rivaroxaban in patients with non-valvular atrial fibrillation in real clinical practice.
Sychev DA, Sokolov AV, Reshetko OV, Fisenko VP, Sychev IN, Grishina EA, Bochkov PO, Shevchenko RV, Abdullaev SP, Denisenko NP, Ivashchenko DV, Sozaeva ZA, Kachanova AA. Sychev DA, et al. Among authors: shevchenko rv. Pharmacogenet Genomics. 2022 Dec 1;32(9):301-307. doi: 10.1097/FPC.0000000000000483. Epub 2022 Oct 13. Pharmacogenet Genomics. 2022. PMID: 36256705
Effect of CES1 and ABCB1 genotypes on the pharmacokinetics and clinical outcomes of dabigatran etexilate in patients with atrial fibrillation and chronic kidney disease.
Sychev D, Skripka A, Ryzhikova K, Bochkov P, Shevchenko R, Krupenin P, Ivashchenko D, Kogay V, Listratov A, Krainyaya A, Gurinovich O, Sokolova A, Napalkov D, Fomin V. Sychev D, et al. Among authors: shevchenko r. Drug Metab Pers Ther. 2020 Mar 5;35(1):/j/dmdi.2020.35.issue-1/dmpt-2019-0029/dmpt-2019-0029.xml. doi: 10.1515/dmpt-2019-0029. Drug Metab Pers Ther. 2020. PMID: 32134727
Factors Affecting Trough Plasma Dabigatran Concentrations in Patients with Atrial Fibrillation and Chronic Kidney Disease.
Skripka A, Sychev D, Bochkov P, Shevchenko R, Krupenin P, Kogay V, Listratov A, Krainyaya A, Gurinovich O, Sokolova A, Napalkov D, Fomin V. Skripka A, et al. Among authors: shevchenko r. High Blood Press Cardiovasc Prev. 2020 Apr;27(2):151-156. doi: 10.1007/s40292-020-00373-2. Epub 2020 Mar 25. High Blood Press Cardiovasc Prev. 2020. PMID: 32215878
164 results